A research team led by Prof. LIU Qingsong from the Hefei Institutes of Physical Science of the Chinese Academy of Science has ...

In preclinical studies, TN-201 showed significant reversal of left ventricular hypertrophy, cardiac dysfunction, and electrophysiological deficits in a severe murine model, which was dose ...

Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disease marked by left ventricular hypertrophy, often due to sarcomere gene mutations. Using transcriptomic, DNA methylomic, and ...

It is often a reversible process that does not cause serious effects on the structure or function of the heart, but if the factor causing cardiac overload becomes chronic, it can lead to ...

In women, HF with T2DM has a relative risk of 1.95 and contributes to cardiac remodeling and LVH, possibly through oxidative stress.3,7 LVH may be brought about by insulin resistance, decreased ...

Left ventricular noncompaction is characterized by deep trabeculations in the LV endocardium in association with left ventricular hypertrophy, dilation or hypertrophy/dilation. Noncompaction of the ...

T-wave3 T-waves represent the recovery period following ventricular depolarization and contraction (referred to as “repolarization”). Normally upright in leads I, II, and V3-V6.

Objectives American-style football (ASF) athletes are at risk for the development of concentric left ventricular hypertrophy (C-LVH), an established cardiovascular risk factor in the general ...

Intensive blood pressure lowering has substantial benefits for both the prevention and treatment of malignant left ventricular hypertrophy, a new analysis of the SPRINT trial shows.